Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+77.1K
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$6.41M
-
Put/Call ratio
-
2.86
-
Number of buys
-
100
-
Number of sells
-
-72
-
Price
-
$33.91
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2017
199 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q2 2017.
Emergent BioSolutions Inc. - Common Stock (EBS) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 54.5M outstanding shares and own 65.38% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.35M shares), VANGUARD GROUP INC (3.55M shares), DIMENSIONAL FUND ADVISORS LP (2.21M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (1.74M shares), GLENMEDE TRUST CO NA (1.73M shares), STATE STREET CORP (1.38M shares), ACADIAN ASSET MANAGEMENT LLC (1.24M shares), SNYDER CAPITAL MANAGEMENT L P (1.09M shares), Invesco Ltd. (971K shares), and ROYAL BANK OF CANADA (959K shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.